1. It is good to see BLDV's focus on revenues ($3 million) and interesting to see them having an MoU for the patient data and delivery mechanisms of cannabis products which I presume relate to the technology packages that they are working on. Plus no R/S!!
2. My other impression of this PR is that it seems that they are thinking things through as it makes sense to have a good delivery mechanism that takes into account patient data in order to have an effective data-based delivery technology that is useable for the end consumer/patient.